REQUEST A DEMO
Total
USD $0.00
Search more companies

Cepilab S.A.S. (Colombia)

Main Activities: Medical Equipment and Supplies Manufacturing
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Cepilab S.A.S. Profile Updated: April 21, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Cepilab S.A.S. is a company in Colombia, with a head office in La Estrella. The enterprise currently operates in the Medical Equipment and Supplies Manufacturing sector. The company was established on May 06, 2021. 40 (2024) employees currently work for Cepilab S.A.S.. There was a net sales revenue increase of 8.64% reported in Cepilab S.A.S.’s latest financial highlights for 2023. A growth of 9.37% was recorded in its total assets. The enterprise’s net profit margin decreased by 0.78% in 2023.

Headquarters
Cl 100 Sur # 49 95 Bg 51
La Estrella; Antioquia;

Contact Details: Purchase the Cepilab S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Cepilab S.A.S. report to view the information.
Outstanding Shares:
Purchase the Cepilab S.A.S. report to view the information.
Incorporation Date:
May 06, 2021
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Cepilab S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
8.64%
Total operating revenue
8.64%
Net Profit (Loss) for the Period
-8.44%
Total assets
9.37%
Total equity
99.67%
Net Profit Margin
-0.78%
Return on Equity (ROE)
-7.22%
Quick Ratio
1.73%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?